Request Demo
Last update 16 May 2025
S-488210
Last update 16 May 2025
Overview
Basic Info
Drug Type Inactivated vaccine, Therapeutic vaccine |
Synonyms RSC-488210, S 488210 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with S-488210NCT04316689
Open-label, Phase 1 Study of S-488210/S-488211 to Evaluate the Safety and Tolerability in Patients With Unresectable Recurrent and/or Metastatic Solid Tumor
EUCTR2011-005014-12-BE
A Phase 1/2 Study to Evaluate the Safety, Tolerability, Immune Response, and Clinical Efficacy of Cancer Peptide Vaccine S-488210 in Patients with Unresectable Locoregionally Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
100 Clinical Results associated with S-488210
Login to view more data
100 Translational Medicine associated with S-488210
Login to view more data
100 Patents (Medical) associated with S-488210
Login to view more data
100 Deals associated with S-488210
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Head and Neck Neoplasms | Phase 2 | Belgium | 13 Nov 2017 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | - | |
| Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | - | |
| Bladder Cancer | Phase 1 | United Kingdom | 30 Jul 2019 | |
| Esophageal Carcinoma | Phase 1 | United Kingdom | 30 Jul 2019 | |
| Lung Cancer | Phase 1 | United Kingdom | 30 Jul 2019 | |
| Mesothelioma | Phase 1 | United Kingdom | 30 Jul 2019 | |
| Relapsed Solid Neoplasm | Phase 1 | United Kingdom | 30 Jul 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free